thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33978723-ED21C59F-85A5-4D72-AE8B-041BA112886D
Q33978723-ED21C59F-85A5-4D72-AE8B-041BA112886D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33978723-ED21C59F-85A5-4D72-AE8B-041BA112886D
Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.
P2860
Q33978723-ED21C59F-85A5-4D72-AE8B-041BA112886D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33978723-ED21C59F-85A5-4D72-AE8B-041BA112886D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5e72f8296352ec685e87f51623dabfb1bfcf8f2
P2860
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease.